Jan 22, 2009 - Antares Pharma, Inc. announced that the Company received a milestone payment from Teva Pharmaceutical Industries Ltd. related to the filing of a Device Master File for a novel disposable pen injector. The pen injector is being developed under a license agreement signed in January 2008 between the companies where Antares will supply a custom proprietary pen for two self-administered drugs that ultimately will be marketed by Teva.
The details can be read here.
No comments:
Post a Comment